MME and Hyperkalemia: There was no difference in chronic renal events (OR 0.92 (0.8-1.05)) or hyperkalemia (OR 1.02 (0.84-1.23)), suggesting that neutral endopeptidase inhibitors (NEPi)+ ACEi/ARBs have a safe record at the renal level.